Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Latest filing published 13 Mar 2023 for Lucira Health, Inc., €9,767.
Filing timeline
BuySaleRichard Clavano Narido
Insider track record
Disclosed buys
0
Disclosed sells
6
Signal history
Richard Clavano Narido: trading record in brief
All filings by Richard Clavano Narido on record concern Lucira Health, Inc. In total, 6 filings cover trades dated from 1 December 2022 to 7 March 2023.
Every open-market trade on record is a sale: 6 sales worth €28k. Since January 2023: no purchases and 5 sales on the market.
The newest entry dates from 13 March 2023: an open-market sale of €9,767, in Lucira Health, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 9 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Richard Clavano Narido
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
9,675 shares@ US$1.0734.5% of flowCommon StockSEC:0001209191-23-018225:1
4,742 shares@ US$1.0015.8% of flowCommon StockSEC:0001209191-23-018225:2
1,910 shares@ US$0.573.6% of flowCommon StockSEC:0001209191-23-018225:3
2,382 shares@ US$0.453.5% of flowCommon StockSEC:0001209191-23-018225:4
10,674 shares@ US$1.1495.5% of flowCommon StockSEC:0001209191-23-018225:0
1,583 shares@ US$0.364.5% of flowCommon StockSEC:0001209191-22-059999:0
6 of 6 declarations
